Delivery Order #SPE2DP26F6331

Delivery Order for Dexamethasone Sodium Under Multi-Year Pharmaceutical Supply Contract

This award is a delivery order contract issued under a previously established indefinite delivery vehicle (IDV) agreement, representing a focused procurement of dexamethasone sodium, an essential pharmaceutical used in various medical treatments. The recipient, DMS Pharmaceutical Group Inc., is a pharmaceutical distributor specializing in supplying critical medications to federal health agencies. The delivery order ensures timely fulfillment of specific drug needs within the broader, multi-year definitive pharmaceutical supply contract that began in 2025 and continues through 2038, underscoring a long-term commitment to supporting public health initiatives. The work involves the provision and delivery of dexamethasone sodium at the designated performance location. This award complements the parent IDV, which covers a comprehensive range of pharmaceuticals including injectable solutions and oral tablets, vital for diverse healthcare requirements. The contract was awarded through the existing procurement vehicle, following a strategic and competitive procurement approach, highlighting the agency's emphasis on reliable and efficient pharmaceutical sourcing. Performance for this order is scheduled for a single day in mid-2026, reflecting a precise and timely acquisition within the established contract framework.

Description

8512160972!DEXAMETHASONE SODIU

View original record